Literature DB >> 31219464

Alelos HLA más comunes y asociados con riesgo o protección en enfermedad renal crónica de etiología no determinada.

Juan Carlos H Hernández-Rivera1, Mariana Salazar-Mendoza2, María Juana Pérez-López3, Jaime González-Ramos4, Ramón Espinoza-Pérez5, Julio César Martínez-Álvarez6, Miguel Trejo-Villeda1, Ramón Paniagua-Sierra1.   

Abstract

INTRODUCTION: Chronic kidney disease accounts for part of overall health expenditure; a potential etiology is related to variations, absence or presence of some human leukocyte antigen (HLA) alleles.
METHOD: An analysis of HLA reports of 1965 kidney recipients with no determined etiology, and 1361 kidney donors was performed. It was carried out with Luminex based in cell flow fluorometry for the A, B, DRB1 and DQA loci. An analysis was performed with contingency tables in order to determine the odds ratio (OR) and confidence intervals (CI). Quantitative analysis was also carried out.
RESULTS: Of the 101 alleles found, 13 showed association, 7 with risk for chronic kidney disease, with the most significant being HLA-DR17 with an OR of 3.91 (95 % CI = 2.96-5.17) and the one with the highest significance for protection being HLA-DR9, with an OR of 0.043 (95 % CI = 0.005-0.3224).
CONCLUSIONS: It is necessary to understand that kidney diseases can be associated with yet unknown immune processes, where the association of the absence or presence of any allele should be known. Copyright:
© 2019 SecretarÍa de Salud.

Entities:  

Keywords:  Alelos; Alleles; Chronic kidney disease; Enfermedad renal crónica; HLA; Human leukocyte antigen; Kidney recipients; Receptores renales

Mesh:

Substances:

Year:  2019        PMID: 31219464     DOI: 10.24875/GMM.19005033

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  1 in total

Review 1.  Systematic review of associations between HLA and renal function.

Authors:  Marcus Lowe; Steven Jervis; Antony Payton; Kay Poulton; Judith Worthington; Isla Gemmell; Arpana Verma
Journal:  Int J Immunogenet       Date:  2021-12-17       Impact factor: 2.385

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.